Search - tctmd.com

Displaying 401 - 420 of 662

Sort: Relevancy | Date

Presentation TCT 2014

Watchman Nightmare Case and Teaching Moment #2: Improper Device Sizing with Embolization

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Vivek Y. Reddy

September 13, 2014

Presentation TCT 2014

Watchman Nightmare Case and Teaching Moment #1: A Perforation

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Maurice Buchbinder

September 13, 2014

Presentation TCT 2014

LAA Closure with the Watchman Device: A Perfect Case (Step-by-Step)

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, Ramon Quesada

September 13, 2014

Presentation TCT 2014

Preprocedure Groundwork: Imaging the LAA and Device Selection

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz

September 13, 2014

Presentation TCT 2014

Hemodynamic and Patient-Care Concerns When Accessing the Left Atrium

Presenter: Marsha Holton, John R. Zimmerman, Jeff Davis

September 13, 2014

Presentation TCT 2014

Fundamental Knowledge: Left Atrial Appendage Anatomy, Function, and Relational Pathology

Presenter: Marsha Holton, John R. Zimmerman, Brij Maini

September 13, 2014

News Daily News

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Yael L. Maxwell

August 07, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

News Daily News

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Yael L. Maxwell

August 07, 2014

Presentation

Early Safety and Efficacy of Percutaneous LAA Suture Ligation

Presenter: Matthew J. Price

August 05, 2014

Presentation LAA 2014

Watchman: Registry Data from the “Real-World”

Presenter: Vivek Y. Reddy

July 19, 2014

Presentation LAA 2014

Watchman: Randomized Trial Data in Anticoagulant Eligible Patients(from PROTECT AF to CAP to PREVAIL)

Presenter: David R. Holmes

July 19, 2014

Presentation LAA 2014

Watchman: Non-Randomized Trial Data in Anticoagulant Ineligible Patients ASAP and more

Presenter: Vivek Y. Reddy

July 19, 2014

Presentation LAA 2014

Use of Integrated 3D TEE-Fluoroscopy for Guidance of LAA Closure

Presenter: John D. Carroll

July 19, 2014

Presentation LAA 2014

The Afib-LAA Closure Heart Team: Constituents and Process

Presenter: Matthew J. Price

July 19, 2014

Presentation LAA 2014

Setting up a LAA Closure Program: the EP perspective

Presenter: Rodney P. Horton

July 19, 2014

Presentation LAA 2014

Safety and Efficacy of the WAVECREST: First-in-Human Experiences and Future Trials

Presenter: Gregg W. Stone

July 19, 2014

Presentation LAA 2014

RT 3D ICE & Future Imaging

Presenter: Brijeshwar Maini

July 19, 2014

Presentation LAA 2014

Outcomes Data with the Amplatzer Cardiac Plug in Anticoagulant Eligible and Ineligible Patients

Presenter: Josep Rod?s-Cabau

July 19, 2014

Presentation LAA 2014

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

Presenter: Maurice Buchbinder

July 19, 2014

Advertisement

Watchman Nightmare Case and Teaching Moment #2: Improper Device Sizing with Embolization

Watchman Nightmare Case and Teaching Moment #1: A Perforation

LAA Closure with the Watchman Device: A Perfect Case (Step-by-Step)

Preprocedure Groundwork: Imaging the LAA and Device Selection

Hemodynamic and Patient-Care Concerns When Accessing the Left Atrium

Fundamental Knowledge: Left Atrial Appendage Anatomy, Function, and Relational Pathology

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Early Safety and Efficacy of Percutaneous LAA Suture Ligation

Watchman: Registry Data from the “Real-World”

Watchman: Randomized Trial Data in Anticoagulant Eligible Patients(from PROTECT AF to CAP to PREVAIL)

Watchman: Non-Randomized Trial Data in Anticoagulant Ineligible Patients ASAP and more

Use of Integrated 3D TEE-Fluoroscopy for Guidance of LAA Closure

The Afib-LAA Closure Heart Team: Constituents and Process

Setting up a LAA Closure Program: the EP perspective

Safety and Efficacy of the WAVECREST: First-in-Human Experiences and Future Trials

RT 3D ICE & Future Imaging

Outcomes Data with the Amplatzer Cardiac Plug in Anticoagulant Eligible and Ineligible Patients

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content